Compare BioNano Genomics Inc (BNGO) vs Marathon Petroleum Corp (MPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Marathon Petroleum Corp — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Marathon Petroleum Corp trades at $345.32 (market cap $94.48B). The key difference: Marathon Petroleum Corp is far larger — about 6916.5× BioNano Genomics Inc's market cap, and Marathon Petroleum Corp pays a 1.19% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | MPC | |
|---|---|---|
Market Cap | $13.66M | $94.48B |
Sector | Health | Energy |
52-Week High | $4.92 | $336.42 |
52-Week Low | $1.06 | $159.11 |
Enterprise Value | $16.26M | $121.00B |
Dividend Yield | — | 1.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
Marathon Petroleum (MPC) trades at $345.68, up 7.92% over 24 hours, with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with a P/E of 11.67 and ROE of 47.9%, supported by recent earnings beats including Q2 2026 EPS of $17.73 versus $14.27 expected. Refining margins remain elevated due to global supply constraints, driving revenue growth projections to $153.6B for 2026.
MPC presents a compelling investment case with strong cash flow generation and shareholder returns via dividends and buybacks. Key risks include exposure to volatile energy markets and geopolitical factors affecting refining margins. Wall Street maintains strong bullish consensus with 76% buy ratings and $332.70 price target, though current price exceeds consensus.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Marathon Petroleum Corp
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →
